Work

The Value of Genetic Testing in Polycystic Kidney Diseases Illustrated by a Family With PKD2 and COL4A1 Mutations

Year: 2018

Type: article

Source: American Journal of Kidney Diseases

DOI: 10.1053/j.ajkd.2017.11.015

Authors: Emilie Cornec-Le Gall, Fouad T. Chebib, Charles D. Madsen, Sarah R. Senum, Christina M. Heyer, Brendan C. Lanpher, Marc C. Patterson, Robert C. Albright, Alan S. Yu, Vicente E. Torres, Kaleab Z. Abebe, Kyongtae T. Bae, Robert W. Schrier, Arlene B. Chapman, Ronald D. Perrone, William E. Braun, Theodore I. Steinman, Peter C. Harris

Institutions: Mayo Clinic, Université de Bretagne Occidentale, University of Kansas Medical Center

Language: English

Topic: Genetic and Kidney Cyst Diseases

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, National Center for Advancing Translational Sciences

Awards: G1413485863, G1664956638, G2007182234, G2188074773, G2220681477, G2279204252, G3433690915, Controlled Trial of Renin Angiotensin Blockade in ADPKD, G5628501904, Limited Competition: Clinical Centers for the HALT-Polycystic Kidney Disease Tria, G690901646, G781754001, Mayo Translational PKD Center (MTPC), ADPKD: Disease Spectrum & Genotype-Phenotype Correlations, G906679193

OpenAlex ID: W2785839643

FWCI: 2.496

Cites: 23

Cited by: 42

Related to: 10